| 1 |
31441020 | Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours. | 2020 Jun |
1 |
| 2 |
30320402 | In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells. | 2019 Jan |
3 |
| 3 |
32123828 | In search of the altering salivary proteome in metastatic breast and ovarian cancers. | 2019 Mar |
1 |
| 4 |
28589243 | RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo. | 2018 Feb |
3 |
| 5 |
28259950 | Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin. | 2017 Apr |
10 |
| 6 |
28334732 | High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients. | 2017 Apr 25 |
4 |
| 7 |
28529574 | Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy. | 2017 May |
6 |
| 8 |
28532857 | High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. | 2017 Aug |
2 |
| 9 |
28534969 | The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro. | 2017 Jul |
9 |
| 10 |
28933054 | High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma. | 2017 Dec |
1 |
| 11 |
29034341 | Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells. | 2017 Sep |
4 |
| 12 |
26148901 | Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients. | 2016 Jan |
2 |
| 13 |
26881937 | Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells. | 2016 Mar |
6 |
| 14 |
27284003 | Direct evidence for the interaction of stathmin along the length and the plus end of microtubules in cells. | 2016 Sep |
2 |
| 15 |
27289016 | Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice. | 2016 Dec |
8 |
| 16 |
25572118 | Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel. | 2015 Apr |
4 |
| 17 |
25894372 | Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer. | 2015 Sep |
4 |
| 18 |
25944168 | Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma. | 2015 Sep |
5 |
| 19 |
26030092 | Stathmin potentiates vinflunine and inhibits Paclitaxel activity. | 2015 |
3 |
| 20 |
26087399 | Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients. | 2015 Sep 8 |
1 |
| 21 |
26356819 | Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells. | 2015 Oct 6 |
1 |
| 22 |
26782519 | Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel. | 2015 Dec 29 |
5 |
| 23 |
24306928 | A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells. | 2014 Feb |
5 |
| 24 |
24708177 | Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. | 2014 Jun |
1 |
| 25 |
25379611 | Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines. | 2014 Nov |
8 |
| 26 |
23229199 | Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma. | 2013 Feb |
1 |
| 27 |
23460921 | Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer. | 2013 |
2 |
| 28 |
23496232 | Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2. | 2013 Jun |
1 |
| 29 |
23618950 | Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer. | 2013 May |
1 |
| 30 |
22281755 | Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells. | 2012 Apr |
2 |
| 31 |
20816848 | Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis. | 2011 Jun 17 |
8 |
| 32 |
21240457 | Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma. | 2011 Mar |
1 |
| 33 |
21546534 | Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention. | 2011 Jul 23 |
2 |
| 34 |
20530690 | FoxM1 mediates resistance to herceptin and paclitaxel. | 2010 Jun 15 |
1 |
| 35 |
19228748 | Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma. | 2009 Feb 15 |
1 |
| 36 |
19322891 | Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel. | 2009 Jun 1 |
5 |
| 37 |
17272681 | Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. | 2007 May |
3 |
| 38 |
17663418 | Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. | 2007 Sep |
1 |
| 39 |
17172428 | Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer. | 2006 Dec |
4 |
| 40 |
12649178 | Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation. | 2003 Mar 15 |
1 |
| 41 |
14654788 | Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells. | 2003 Dec 4 |
1 |
| 42 |
12460900 | Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. | 2002 Dec 1 |
2 |
| 43 |
12480194 | Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer. | 2002 Dec |
1 |
| 44 |
11181174 | Effects of stathmin inhibition on the mitotic spindle. | 2001 Mar |
1 |
| 45 |
10910066 | Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. | 2000 Jul 1 |
2 |
| 46 |
10022911 | Mutations of oncoprotein 18/stathmin identify tubulin-directed regulatory activities distinct from tubulin association. | 1999 Mar |
1 |